This page contains exclusive content for the member of the following sections: TTS, CTS, IPITA, ISODP, IXA, ITA, TID, IHCTAS, IPTA, SPLIT, ISUTX. Log in to view.
2024-2026 - TTS Education Webinar Series
10727.24 - Understanding Frailty and Infections in Older Transplant Recipients
Presenter: Mara McAdams-DeMarco, Maricar Malinis, Robert Pol, , , Authors: Mara McAdams-DeMarco, Maricar Malinis, Robert Pol, Sarah Taimur, Maheen Abidi
Overview
This session will explore the role of frailty and other aging-related metrics in older adults undergoing kidney transplantation. The discussion will begin with an overview of the importance of assessing measures of aging—such as frailty, physical function, and cognitive function—during the kidney transplant evaluation process. It will also address how frailty and cognitive function may change after transplantation and how these trajectories influence key post-transplant outcomes. Particular attention will be given to the association between frailty and adverse outcomes, including mortality, graft loss, early hospital readmissions, and cognitive decline among older kidney transplant recipients.
The session will also examine the bi-directional relationship between frailty and infections in older transplant recipients. Common infections—such as herpes zoster, influenza, and recurrent urinary tract infections—will be discussed in the context of how frailty may increase susceptibility to infection and how infections, in turn, may worsen frailty and contribute to poor post-transplant outcomes. Preventive strategies, including infection prophylaxis, vaccination, and considerations regarding vaccine effectiveness in older adults, will also be reviewed.
In addition, the session may highlight commonly used frailty assessment tools that have been applied in transplant populations. These include the Fried Frailty Phenotype and several frailty indices, such as the Rockwood 20-Item Frailty Index, the Lekan Frailty Score, and the Modified Frailty Index. The overview will emphasize how these tools have been used in research and clinical practice to evaluate frailty and better understand its relationship with infections and other post-transplant outcomes in older organ transplant recipients.
Objectives
Learners will develop an understanding of different frailty assessment tools that can be utilized both for clinical evaluations as well as for purposes of research.
Understand the impact of frailty on post-transplant outcomes including mortality and graft-loss in older adults.
How infections can further worsen the trajectory of frailty and post-transplant outcomes in the frail elder organ transplant recipients.
The frailty symposium highlights the urgent and unmet needs of future studies involving frailty and infections.
Associate Professor of Medicine
Transplant Infectious Diseases
Icahn School of Medicine at Mount Sinai
New York, NY
Dr. Sarah Taimur specializes in infectious diseases with a focus on the immunosuppressed host. Her clinical work includes consultation on oncology patients, candidates and recipients of solid organ and hematopoietic stem cell transplantation. Her research interests include fraility in transplantation, multi-drug resistant infections after transplant, and mechanical circulatory device infections.
Infectious Disease Specialist
Mayo Clinic, Pheonix
Dr. Maheen Z. Abidi is an Associate Professor of Medicine in Transplant Infectious Diseases at Mayo Clinic Arizona. Dr. Abidi is a past recipient of an NIA-C K23 Award (2021-2025) titled CMV and CMV-Immune Responses in Geriatric Conditions Post-Kidney Transplant. Dr. Abidi’s current investigations leverage national registry data from the Scientific Registry of Transplant Recipients (SRTR) to evaluate CMV-related outcomes in older adults following organ transplantation. She is an active member of the the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), including its Study Groups on Infections in the Elderly (ESGIE) and Infections in Compromised Hosts (ESGICH). Dr. Abidi is currently serving as a member-at-large on the Organ Procurement and Transplantation Network (OPTN) Disease Transmission Advisory Committee (DTAC) for the 2023–2027 term.
Associate Professor of Medicine and Surgery
Medical Director
Transplant Infectious Diseases
Vanderbilt University Medical Center, Nashville
Maricar Malinis, MD is an Associate Professor of Medicine and Surgery (Transplant) and the Medical Director of Transplant Infectious Diseases at Vanderbilt University Medical Center, Nashville, TN, USA. She completed trainings in Infectious Diseases, Geriatric Medicine and Transplant Infectious Diseases. She has been active in several national and international societies She is currently a councilor of the TID-TTS and the chair of the IDSA Immunocompromised Host Community of Practice. She is focused on clinical research involving transplant outcomes of older adults and people living with HIV.
Faculty Medicine, Wetenschappen/UMCG,
Groningen Institute for Organ
Transplant (GIOT), Groningen Kidney Center (GKC)
Important
Disclaimer
By viewing the material on this site you understand and
accept that:
The opinions and statements expressed on this site reflect the
views of the author or authors and do not necessarily reflect those of
The Transplantation Society and/or its Sections.
The hosting of material on The Transplantation Society site does
not signify endorsement of this material by The Transplantation Society
and/or its Sections.
The material is solely for educational purposes for qualified
health care professionals.
The Transplantation Society and/or its Sections are not liable for
any decision made or action taken based on the information contained in
the material on this site.
The information cannot be used as a substitute for professional
care.
The information does not represent a standard of care.
No physician-patient relationship is being established.